Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity

Cell Death and Disease

Volumn 4, Issue 12, 2013, Pages

  Kim, J T ^a   Lee, S J ^a   Kang, M A ^a   Park, J E ^a   Kim, B Y ^a   Yoon, D Y ^b   Yang, Y ^c   Lee, C H ^a   Yeom, Y I ^a   Choe, Y K ^a   Lee, H G ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Konkuk University   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

Cathepsin B; colon cancer; Cystatin C; cystatin SN; invasion

Indexed keywords

CATHEPSIN B; CYSTATIN C; CYSTATIN S; CYSTATIN SN; DISULFIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; CELL STRAIN HCT116; CELLULAR DISTRIBUTION; COLON CARCINOGENESIS; COLON TUMOR; CONFORMATION; CONTROLLED STUDY; DISULFIDE BOND; ENZYME ACTIVITY; EXTRACELLULAR SPACE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CATHEPSIN B; CELL LINE; COLONIC NEOPLASMS; CYSTATIN C; HCT116 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY CYSTATINS;

EID: 84891786698     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.485     Document Type: Article

References (43)

1. Berdowska I. Cysteine proteases as disease markers. Clin Chim Acta 2004; 342: 41-69
2. Overall CM, Kleifeld O. Tumour microenvironment-opinion: Validating matrix metalloproteinases as drug targets and anti-Targets for cancer therapy. Nat Rev Cancer 2006; 6: 227-239
3. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta 2000; 291: 113-135
4. Lah TT, Babnik J, Schiffmann E, Turk V, Skaleric U. Cysteine proteinases and inhibitors in inflammation: Their role in periodontal disease. J Periodontol 1993; 64: 485-491
5. Travis J, Potempa J. Bacterial proteinases as targets for the development of secondgeneration antibiotics. Biochim Biophys Acta 2000; 1477: 35-50
6. Turk V, Turk B, Turk D. Lysosomal cysteine proteases: Facts and opportunities. EMBO J. 2001; 20: 4629-4633
7. Mohamed MM, Sloane BF. Cysteine cathepsins: Multifunctional enzymes in cancer. Nat Rev Cancer 2006; 6: 764-775
8. Bell-McGuinn KM, Garfall AL, Bogyo M, Hanahan D, Joyce JA. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer. Cancer Res 2007; 67: 7378-7385
9. Premzl A, Zavasnik-Bergant V, Turk V, Kos J. Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp Cell Res 2003; 283: 206-214
10. Sever N, Filipic M, Brzin J, Lah TT. Effect of cysteine proteinase inhibitors on murine B16 melanoma cell invasion in vitro. Biol Chem 2002; 383: 839-842
11. Barrett AJ. The cystatins: A diverse superfamily of cysteine peptidase inhibitors. Biomed Biochim Acta 1986; 45: 1363-1374
12. Lindahl P, Abrahamson M, Bjork I. Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. Biochem J 1992; 281(Pt 1): 49-55
13. Dickinson DP, Zhao Y, Thiesse M, Siciliano MJ. Direct mapping of seven genes encoding human type 2 cystatins to a single site located at 20p11.2. Genomics 1994; 24: 172-175
14. Thiesse M, Millar SJ, Dickinson DP. The human type 2 cystatin gene family consists of eight to nine members, with at least seven genes clustered at a single locus on human chromosome 20. DNA Cell Biol 1994; 13: 97-116
15. Bobek LA, Levine MJ. Cystatins-inhibitors of cysteine proteinases. Crit Rev Oral Biol Med 1992; 3: 307-332
16. Henskens YM, Veerman EC, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe Seyler 1996; 377: 71-86
17. Buttle DJ, Burnett D, Abrahamson M. Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: Relationship to inflammation. Scand J Clin Lab Invest 1990; 50: 509-516
18. Bell JE, Cunningham E, Belt C, Featherstone JD, Bell J. Examination of the potential structure of human salivary cystatins based on computer modelling. Arch Oral Biol 1997; 42: 761-772
19. Bobek LA, Ramasubbu N, Wang X, Weaver TR, Levine MJ. Biological activities and secondary structures of variant forms of human salivary cystatin SN produced in Escherichia coli. Gene 1994; 151: 303-308
20. Baron A, DeCarlo A, Featherstone J. Functional aspects of the human salivary cystatins in the oral environment. Oral Dis 1999; 5: 234-240
21. Tseng CC, Tseng CP, Levine MJ, Bobek LA. Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system. Arch Biochem Biophys 2000; 380: 133-140
22. Abrahamson M, Dalboge H, Olafsson I, Carlsen S, Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett 1988; 236: 14-18
23. Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL et al. Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer 1999; 83: 526-531
24. Cox JL, Sexton PS, Green TJ, Darmani NA. Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. Melanoma Res 1999; 9: 369-374
25. Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brunner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: Relation to prognosis. Clin Cancer Res 2000; 6: 505-511
26. Haider AS, Peters SB, Kaporis H, Cardinale I, Fei J, Ott J et al. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 2006; 126: 869-881
27. Vigneswaran N, Wu J, Zacharias W. Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. Oral Oncol 2003; 39: 559-568
28. Choi EH, Kim JT, Kim JH, Kim SY, Song EY, Kim JW et al. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. Clin Chim Acta 2009; 406: 45-51
29. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A et al. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J 1988; 7: 2593-2599
30. Martin JR, Craven CJ, Jerala R, Kroon-Zitko L, Zerovnik E, Turk V et al. The three-dimensional solution structure of human stefin A. J Mol Biol 1995; 246: 331-343
31. Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI et al. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 1997; 173: 423-432
32. Barka T, van der Noen H, Patil S. Cysteine proteinase inhibitor in cultured human medullary thyroid carcinoma cells. Lab Invest 1992; 66: 691-700
33. Mulaomerovic A, Halilbasic A, Cickusic E, Zavasnik-Bergant T, Begic L, Kos J. Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma. Cancer Lett 2007; 248: 192-197
34. Sotiropoulou G, Anisowicz A, Sager R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem 1997; 272: 903-910
35. Cegnar M, Kos J, Kristl J. Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles. J Nanosci Nanotechnol 2006; 6: 3087-3094
36. Hiltke TR, Lee TC, Bobek LA. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN. J Dent Res 1999; 78: 1401-1409
37. Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M et al. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001; 8: 316-320
38. Janowski R, Kozak M, Abrahamson M, Grubb A, Jaskolski M. 3D domain-swapped human cystatin C with amyloidlike intermolecular beta-sheets. Proteins 2005; 61: 570-578
39. Bjarnadottir M, Nilsson C, Lindstrom V, Westman A, Davidsson P, Thormodsson F et al. The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid 2001; 8: 1-10
40. Olafsson I, Grubb A. Hereditary cystatin C amyloid angiopathy. Amyloid 2000; 7: 70-79
41. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV et al. A 'silent' polymorphismin the MDR1 gene changes substrate specificity. Science 2007; 315: 525-528
42. Kos J, Nielsen H-J, Krašovec M, Christensen IJ, Cimerman N, Stephens RW et al. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res 1998; 4: 1511-1516
43. Kos J, Š tabuc B, Schweiger A, Krašovec M, Cimerman N, Kopitar-Jerala N et al. Cathepsins B, H, L, and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 1997; 3: 1815-1822